Antigenics (AGEN) Announces Positive Results With Herpes Treatment AG-707

Go back to Antigenics (AGEN) Announces Positive Results With Herpes Treatment AG-707
AGENUS (NASDAQ: AGEN) Delayed: 8.26 --0 (-0%)
Previous Close $8.26    52 Week High $7.49 
Open $8.26    52 Week Low $2.61 
Day High $8.26    P/E N/A 
Day Low $8.26    EPS $-1.10 
Volume 319